[HTML] nih.gov

[HTML][HTML] Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention

NM Davis, M Sokolosky, K Stadelman, SL Abrams… - Oncotarget, 2014 - ncbi.nlm.nih.gov
Abstract The EGFR/PI3K/PTEN/Akt/mTORC1/GSK-3 pathway plays prominent roles in
malignant transformation, prevention of apoptosis, drug resistance and metastasis. The …
被引用次数：324 相关文章

Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.

NM Davis, M Sokolosky, K Stadelman… - 2014 - publications.goettingen-research …
The EGFR/PI3K/PTEN/Akt/mTORC1/GSK-3 pathway plays prominent roles in malignant
transformation, prevention of apoptosis, drug resistance and metastasis. The expression of …
[PDF] academia.edu

[PDF][PDF] Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention

NM Davis, M Sokolosky, K Stadelman, SL Abrams… - academia.edu
ABSTRACT The EGFR/PI3K/PTEN/Akt/mTORC1/GSK-3 pathway plays prominent roles in
malignant transformation, prevention of apoptosis, drug resistance and metastasis. The …
[HTML] oncotarget.com

[HTML][HTML] Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention

NM Davis, M Sokolosky, K Stadelman, SL Abrams… - Oncotarget, 2014 - oncotarget.com
Abstract Nicole M. Davis 1, Melissa Sokolosky 1, Kristin Stadelman 1, Stephen L. Abrams 1,
Massimo Libra 2, Saverio Candido 2, Ferdinando Nicoletti 2, Jerry Polesel 3, Roberta …

[引用][C] Deregulation of the EGFR/pI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention

N Davis, M Sokolosky, K Stadelman, S Abrams… - ONCOTARGET, 2014 - iris.unipa.it

[引用][C] Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: Possibilities for therapeutic intervention

NM Davis, M Sokolosky, K Stadelman, SL Abrams… - Oncotarget, 2014 - elibrary.ru

Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention

NM Davis, M Sokolosky, K Stadelman, SL Abrams… - 2014 - thescholarship.ecu.edu
ABSTRACT The EGFR/PI3K/PTEN/Akt/mTORC1/GSK-3 pathway plays prominent roles in
malignant transformation, prevention of apoptosis, drug resistance and metastasis. The …
[PDF] uj.edu.pl

[PDF][PDF] Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention

NM Davis, M Sokolosky, K Stadelman, SL Abrams… - 2014 - ruj.uj.edu.pl
ABSTRACT The EGFR/PI3K/PTEN/Akt/mTORC1/GSK-3 pathway plays prominent roles in
malignant transformation, prevention of apoptosis, drug resistance and metastasis. The …

[引用][C] Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention

NM Davis, M Sokolosky, K Stadelman, SL Abrams… - Oncotarget, 2014 - cir.nii.ac.jp
Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities
for therapeutic intervention | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.

NM Davis, M Sokolosky, K Stadelman, SL Abrams… - Oncotarget, 2014 - europepmc.org
Abstract The EGFR/PI3K/PTEN/Akt/mTORC1/GSK-3 pathway plays prominent roles in
malignant transformation, prevention of apoptosis, drug resistance and metastasis. The …